Receptor versus non-receptor mediated clearance of liposomes

Advanced Drug Delivery Reviews

Volumn 32, Issue 1-2, 1998, Pages 81-97

  Scherphof, Gerrit L ^a   Kamps, Jan A A M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Apolipoproteins; Lipoprotein (receptor); Opsonins; Phosphatidylserine; Scavenger receptor; Targeting

Indexed keywords

DRUG INTERACTIONS; HEMODYNAMICS; PROTEINS; SURFACE TREATMENT;

LIPOSOMES; OPSONINS; PHOSPHATIDYLSERINE;

CONTROLLED DRUG DELIVERY;

APOLIPOPROTEIN; COMPLEMENT RECEPTOR; LIPOPROTEIN; LIPOSOME; PHOSPHATIDYLSERINE; SCAVENGER RECEPTOR;

CELL INTERACTION; CELL POPULATION; DRUG CLEARANCE; LIVER CLEARANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW;

EID: 0032496677     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00133-6     Document Type: Review

References (113)

1. Blumenthal R., Weinstein J.N., Sharrow S.O., Henkart P. Liposome-lymphocyte interaction: Saturable sites for transfer and intracellular release of liposome contents. Proc. Natl. Acad. Sci. USA. 74:1977;5603-5607.
2. Huang L., Ozato K., Pagano R.E. Interactions of phospholipid vesicles with murine lymphocytes. I. Vesicle-cell adsorption and fusion as alternate pathways of uptake. Membr. Biochem. 1:1978;1-25.
3. Jansons V.K., Weis P., Chen T., Redwood W.R. In vitro interaction of L1210 cells with phospholipid vesicles. Cancer Res. 38:1978;530-535.
4. Kuhn S.H., Gemperli B., Shephard E.G., Joubert J.R., Weidemann P.A., Weissmann G., Finkelstein M.C. Interaction of liposomes with human leukocytes in whole blood. Biochim. Biophys. Acta. 762:1983;119-127.
5. Sandra A., Pagano R.E. Liposome-cell interactions. Studies of lipid transfer using isotopically asymmetric vesicles. J. Biol. Chem. 254:1979;2244-2249.
6. Pagano R.E., Takeichi M. Adhesion of phospholipid vesicles to Chinese hamster fibroblasts. Role of cell surface proteins. J. Cell Biol. 74:1977;531-546.
7. Kercret H., Chiovetti R. Jr., Foundatin M.W., Segrest J.P. Plasma membrane-mediated leakage of liposomes induced by interaction with murine thymocytic leukema cells. Biochim. Biophys. Acta. 733:1983;65-74.
8. Blumenthal R., Ralston E., Dragsten P., Leserman L.D., Weinstein J.N. Lipid vesicle-cell interactions: Analysis of a model for transfer of contents from adsorbed vesicles to cells. Membr. Biochem. 4:1982;283-303.
9. Pagano R.E., Weinstein J.N. Interactions of liposomes with mammalian cells. Annu. Rev. Biophys. Bioeng. 7:1978;435-468.
10. Margolis L.B. Cell interaction with model membranes: Probing, modification and simulation of cell surface functions. Biochim. Biophys. Acta. 779:1984;161-189.
11. Straubinger R.M., Hong K., Friend D.S., Papahadjopoulos D. Endocytosis of liposomes and intracellular fate of encapsulated molecules: Encounter with a low pH compartment after internalization in coated vesicles. Cell. 32:1983;1069-1079.
12. Pagano R.E., Huang L. Interaction of phospholipid vesicles with cultured mammalian cells. II. Studies of mechanism. J. Cell Biol. 67:1975;49-60.
13. Margolis L.B., Neyfakh A.A. Jr. The distribution of solid liposomes of different size on the surface of epithelial cells. Eur. J. Cell Biol. 31:1983;256-262.
14. Mayhew E., Gotfredsen C., Schneider Y.J., Trouet A. Interaction of liposomes with cultured cells: Effect of serum. Biochem. Pharmacol. 29:1980;877-886.
15. Dijkstra J., Van Galen M., Scherphof G. Influence of liposome charge on the association of liposomes with Kupffer cells in vitro. Effects of divalent cations and competition with latex particles. Biochim. Biophys. Acta. 813:1985;287-297.
16. Hsu M.J., Juliano R.L. Interactions of liposomes with the reticuloendothelial system. II: Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. Biochim. Biophys. Acta. 720:1982;411-419.
17. Wassef N.M., Roerdink F., Richardson E.C., Alving C.R. Suppression of phagocytic function and phospholipid metabolism in macrophages by phosphatidylinositol liposomes. Proc. Natl. Acad. Sci. USA. 81:1984;2655-2659.
18. Raz A., Bucana C., Fogler W.E., Poste G., Fidler I.J. Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Res. 41:1981;487-494.
19. Schroit A.J., Fidler I.J. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. Cancer Res. 42:1982;161-167.
20. Mehta K., Lopez-Berestein G., Hersh E.M., Juliano R.L. Uptake of liposomes and liposome-encapsulated MDP by human peripheral blood monocytes. J. Reticuloendothel. Soc. 32:1982;155-164.
21. Dijkstra J., Van Galen M., Scherphof G.L. Effects of ammonium chloride and chloroquine on endocytic uptake of liposomes by Kupffer cells in vitro. Biochim. Biophys. Acta. 804:1984;58-67.
22. Dijkstra J., Van Galen W.J., Hulstaert C.E., Kalicharan D., Roerdink F.H., Scherphof G.L. Interaction of liposomes with Kupffer cells in vitro. Exp. Cell Res. 150:1984;161-176.
23. Dijkstra J., Van Galen M., Regts D., Scherphof G. Uptake of processing of liposomal phospholipids by Kupffer cells in vitro. Eur. J. Biochem. 148:1985;391-397.
24. Dijkstra J., Van Galen M., Scherphof G. Effects of (dihydro)cytochalasin B, colchicin, monensin and trifluoperazine and processing of liposomes by Kupffer cells in culture. Biochim. Biophys. Acta. 845:1985;34-42.
25. Alving C.R., Steck E.A., Chapman W.L. Jr., Waits V.B., Hendricks L.D., Swartz G.M. Jr., Hanson W.L. Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs. Proc. Natl. Acad. Sci. USA. 75:1978;2959-2963.
26. New R.R., Chance M.L., Thomas S.C., Peters W. Antileishmanial activity of antimonials entrapped in liposomes. Nature. 272:1978;55-56.
27. Fidler I., Sone S., Fogler W.E., Barnes Z.L. Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc. Natl. Acad. Sci. USA. 79:1981;1680-1684.
28. Phillips N.C., Tsao M.-S. Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice. Cancer Immunol. Immunother. 33:1991;85-90.
29. Daemen T., Veninga A., Roerdink F.H., Scherphof G.L. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide. Cancer Res. 46:1986;4330-4335.
30. Lee K.D., Hong K., Papahadjopoulos D. Recognition of liposomes by cells: In vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density. Biochim. Biophys. Acta. 1103:1992;185-197.
31. Lee K.D., Pitas R.E., Papahadjopoulos D. Evidence that the scavenger receptor is not involved in the uptake of negatively charged liposomes by cells. Biochim. Biophys. Acta. 1111:1992;1-6.
32. Lee K.D., Nir S., Papahadjopoulos D. Quantitative analysis of liposome-cell interactions in vitro: Rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes. Biochemistry. 32:1993;889-899.
33. Fraley R., Straubinger R.M., Rule G., Springer L., Papahadjopoulos D. Liposome-mediated delivery of deoxyribonucleic acid to cells: Enhanced efficiency of delivery related to lipid composition and incubation conditions. Biochemistry. 20:1981;6978-6987.
34. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76:1979;333-337.
35. Spanjer H.H., Van Galen M., Roerdink F.H., Regts J., Scherphof G.L. Intrahepatic distribution of small unilamellar liposomes as a function of liposomal lipid composition. Biochim. Biophys. Acta. 863:1986;224-230.
36. Leserman L.D., Weinstein J.N., Blumenthal R., Terry W.D. Receptor-mediated endocytosis of antibody-opsonized liposomes by tumor cells. Proc. Natl. Acad. Sci. USA. 77:1980;4089-4093.
37. Suzuki H., Zelphati O., Hildebrand G., Leserman L. CD4 and CD7 molecules as targets for drug delivery from antibody bearing liposomes. Exp. Cell Res. 193:1991;112-119.
38. Jones M.N. Carbohydrate-mediated liposomal targeting and drug delivery. Adv. Drug Deliv. Rev. 13:1994;215-250.
39. Derksen J.T., Morselt H.W., Kalicharan D., Hulstaert C.E., Scherphof G.L. Interaction of immunoglobulin-coupled liposomes with rat liver macrophages in vitro. Exp. Cell Res. 168:1987;105-115.
40. Derksen J.T., Morselt H.W., Scherphof G.L. Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages. Biochim. Biophys. Acta. 931:1987;33-40.
41. Kamps J.A., Swart P.J., Morselt H.W.M., Pauwels R., De Bethune M.P., De Clercq E., Meijer D.K., Scherphof G.L. Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: Drug carriers with an intrinsic anti-HIV activity. Biochim. Biophys. Acta. 1278:1996;183-190.
42. Kamps J.A.A.M., Morselt H.W.M., Scherphof G.L. Interaction of liposomes containing different mol fractions of phosphatidylserine with liver cells: In vivo-in vitro differences. Prog. Drug Deliv. Syst. 5:1996;89-92.
43. Mori A., Kennel S.J., Van Borssum Waalkes M., Scherphof G.L., Huang L. Characterization of organ-specific immunoliposomes for delivery of 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine in a mouse lung-metastasis model. Cancer Chemother. Pharmacol. 35:1995;447-456.
44. Maruyama K., Mori A., Bhadra S., Subbiah M.T., Huang L. Proteins and peptides bound to long-circulating liposomes. Biochim. Biophys. Acta. 1070:1991;246-252.
45. Chonn A., Semple S.C., Cullis P.R. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J. Biol. Chem. 267:1992;18759-18765.
46. Rossi J.D., Wallace B.A. Binding of fibronection to phospholipid vesicles. J. Biol. Chem. 258:1983;3327-3331.
47. Devine D.V., Wong K., Serrano K., Chonn A., Cullis P.R. Liposome-complement interactions in rat serum: Implications for liposome survival studies. Biochim. Biophys. Acta. 1191:1994;43-51.
48. Harashima H., Sakata K., Funato K., Kiwada H. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm. Res. 11:1994;402-406.
49. Chonn A., Semple S.C., Cullis P.R. Beta2-glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of 'non-self' particles. J. Biol. Chem. 270:1995;25845-25849.
50. Richards G.L., Gewurz H., Siegel J., Alving C.R. Interaction of CRP and complement with liposomes, II. Influence of membrane composition. J. Immunol. 122:1979;1185-1189.
51. Volanakis J.E., Narkates A.J. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement. J. Immunol. 126:1981;1820-1825.
52. Murai M., Aramaki Y., Tsuchiya S. Identification of the serum factor required for liposome-primed activation of mouse peritoneal macrophages. Modified alpha2-macroglobulin enhances Fc receptor-mediated phagocytosis of opsonized sheep red blood cells. Immunology. 86:1995;64-70.
53. Schroit A.J., Madsen J.W., Tanaka Y. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J. Biol. Chem. 260:1985;5131-5138.
54. Savill J., Fadok V., Henson P., Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today. 14:1993;131-136.
55. B. Roelofsen, J.A.F. Op den Kamp, Plasma membrane phospholipid asymmetry and its maintenance: The human erythrocyte as a model, in: D. Hoekstra (Ed.), Current Topics in Membranes, Academic Press, San Diego, 1994, pp. 7-46.
56. Liu D., Liu F., Song Y.K. Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin. Biochim. Biophys. Acta. 1235:1995;140-146.
57. Chonn A., Semple S.C., Cullis P.R. Separation of large unilamellar liposomes from blood components by a spin column procedure: Towards identifying plasma proteins which mediate liposome clearance in vivo. Biochim. Biophys. Acta. 1070:1991;215-222.
58. Liu D., Hu Q., Song Y.K. Liposome clearance from blood: Different animal species have different mechanisms. Biochim. Biophys. Acta. 1240:1995;277-284.
59. Krieger M., Herz J. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63:1994;601-637.
60. Allen T.M., Williamson P., Schlegel R.A. Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface. Proc. Natl. Acad. Sci. USA. 85:1988;8067-8071.
61. Rigotti A., Acton S.L., Krieger M. The class B scavenger receptors SR-B1 and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 270:1995;16221-16224.
62. Nishikawa K., Arai H., Inoue K. Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. J. Biol. Chem. 265:1990;5226-5231.
63. Acton S.L., Scherer P.E., Lodish H.F., Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269:1994;21003-21009.
64. Fukasawa M., Adachi H., Hirota K., Tsujimoto M., Arai H., Inoue K. SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. Exp. Cell Res. 222:1996;246-250.
65. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271:1996;518-520.
66. De Rijke Y.B., Van Berkel T.J. Rat liver Kupffer and endothelial cells express different binding proteins for modified low density lipoproteins. Kupffer cells express a 95-kDa membrane protein as a specific binding site for oxidized low density lipoproteins. J. Biol. Chem. 269:1994;824-827.
67. Ottnad E., Parthasarathy S., Sambrano G.R., Ramprasad M.P., Quehenberger O., Kondratenko N., Green S., Steinberg D. A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: Partial purification and role in recognition of oxidatively damaged cells. Proc. Natl. Acad. Sci. USA. 92:1995;1391-1395.
68. Sambrano G.R., Steinberg D. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: Role of membrane phosphatidylserine. Proc. Natl. Acad. Sci. USA. 92:1995;1396-1400.
69. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:1992;2207-2216.
70. Allen T.M., Hansen C., Martin F., Redemann C., Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta. 1066:1991;29-36.
71. Klibanov A.L., Maruyama K., Beckerleg A.M., Torchilin V.P., Huang L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta. 1062:1991;142-148.
72. Kataoka T., Williamson J.R., Kinsky S.C. Release of macromolecular markers (enzymes) from liposomes treated with antibody and complement. An attempt at correlation with electron microscopic observations. Biochim. Biophys. Acta. 298:1973;158-179.
73. Cunningham C.M., Kingzette M., Richards R.L., Alving C.R., Lint Th.F., Gewurz H. Activation of human complement by liposomes: A model for membrane activation of the alternative pathway. J. Immunol. 122:1979;1237-1242.
74. Funato K., Yoda R., Kiwada H. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in fresh rat plasma. Biochim. Biophys. Acta. 1103:1992;198-204.
75. Liu D., Song Y.K., Liu F. Antibody dependent, complement mediated liver uptake of liposomes containing GM1. Pharm. Res. 12:1995;1775-1780.
76. Roerdink F., Wassef N.M., Richardson E.C., Alving C.R. Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement. Biochim. Biophys. Acta. 734:1983;33-39.
77. Szebeni J., Wassef N.M., Spielberg H., Rudolph A.S., Alving C.R. Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: Evidence for anti-lipid antibodies and alternative pathway activation. Biochem. Biophys. Res. Commun. 205:1994;255-263.
78. Richards G.L., Gewurz H., Osmand A.L., Alving C.R. Interaction of C-reactive protein and complement with liposomes. Proc. Natl. Acad. Sci. USA. 74:1977;5672-5676.
79. Richards G.L., Gewurz H., Siegel J., Alving C.R. Interactions of C-reactive protein and complement with liposomes. J. Immunol. 122:1979;1185-1189.
80. Mold C., Gewurz H. Activation of human complement by liposomes: Serum factor requirement for alternative pathway activation. J. Immunol. 125:1980;696-700.
81. Alving C.R., Richards R.L., Guirguis A.A. Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes. J. Immunol. 118:1977;342-347.
82. Greenberg C.S., Hammerschmidt D.E., Craddock P.R., Jacob H.S. Atheroma cholesterol activates complement and aggregates granulocytes: Possible role in ischemic manifestation of atherosclerosis. Trans. Assoc. Am. Physicians. 92:1979;130-135.
83. Marjan J., Xie Z., Devine D.V. Liposome-induced activation of the classical complement pathway does not require immunoglobulin. Biochim. Biophys. Acta. 1192:1994;35-44.
84. Patel H.M. Serum opsonins and liposomes: Their interaction and opsonophagocytosis. Crit. Rev. Ther. Drug Carrier Syst. 9:1992;39-90.
85. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol hemeostasis. Science. 232:1986;34-47.
86. Salter A.M., Bridnley D.N. The biochemistry of lipoproteins. J. Inherit. Metab. Dis. 11:1988;4-17.
87. Guo L.S., Hamilton R.L., Goerke J., Weinstein J.N., Havel R.J. Interaction of unilamellar liposomes with serum lipoproteins and apolipoproteins. J. Lipid Res. 21:1980;993-1003.
88. Jonas A. A review of plasma apolipoprotein A-I interactions with phosphatidylcholines. Exp. Lung Res. 6:1984;255-270.
89. Bisgaier C.L., Siebenkas M.V., Williams K.J. Effects of apolipoproteins A-IV and A-I on uptake of phospholipid liposomes by hepatocytes. J. Biol. Chem. 264:1989;862-866.
90. Mendez A.J., He J.L., Huang H.S., Wen S.R., Hsia S.L. Interaction of rabbit lipoproteins and red blood cells with liposomes of egg yolk phospholipids. Lipids. 23:1988;961-967.
91. Williams K.J., Tall A.R., Bisgaier C., Brocia R. Phospholipid liposomes acquire apolipoprotein E in atherogenic plasma and block cholesterol loading of cultured macrophages. J. Clin. Invest. 79:1987;1466-1472.
92. Scherphof G.L., Morselt H., Allen T.M. Intrahepatic distributions of long-circulating liposomes containing poly(ethylene glycol) distearoyl phosphatidylethanolamine. J. Liposome Res. 4:1994;213-228.
93. Scherphof G., Velinova M., Kamps J., Donga J., Van der Want J., Kuipers F., Havekes L., Daemen R. Modulation of pharmacokinetic behavior of liposomes. Adv. Drug Deliv. Rev. 24:1997;179-191.
94. Van Dijk M.C., Ziere G.J., Boers W., Linthorst C., Bijsterbosch M.K., Van Berkel T.J. Recognition of chylomicron remnants and beta-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver alpha 2-macroglobulin-recognition site. Biochem. J. 279:1991;863-870.
95. De Water R., Kamps J.A., Van Dijk M.C., Hessels E.A., Kuiper J., Kruijt J.K., Van Berkel T.J. Characterization of the low-density-lipoprotein-receptor-independent interaction of beta-very-low-density lipoprotein with rat and human parenchymal liver cells in vitro. Biochem. J. 282:1992;41-48.
96. De Faria E., Fong L.G., Komaromy M., Cooper A.D. Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver. J. Lipid Res. 37:1996;197-209.
97. P.C.N. Rensen, N. Herijgers, M.-H. Netscher, S.C.J. Meskers, M. Van Eck, Th.J.C. Van Berkel, Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo, J. Lipid Res., in press.
98. Pieters M.N., Schouten D., Van Berkel T.J. In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport. Biochim. Biophys. Acta. 1225:1994;125-134.
99. Steinberg D. A docking receptor for HDL cholesterol esters (comment). Science. 271:1996;460-461.
100. Landschulz K.T., Pathak R.K., Rigotti A., Krieger M., Hobbs H.H. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J. Clin. Invest. 98:1996;984-995.
101. Krieger M., Scton S., Ashkenas J., Pearson A., Penman M., Resnick D. Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J. Biol. Chem. 268:1993;4569-4572.
102. Klimov A.N., Korovkin B.F., Kuznetsov A.S., Popov I.N. Apolipoprotein B of plasma lipoproteins incorporated in liposomes: Immunological properties and organ distribution when administered to rabbits. Biull. Eksp. Biol. Med. 96:1983;47-50.
103. Lundberg B., Hong K., Papahadjopoulos D. Conjugation of apolipoprotein B with liposomes and targeting to cells in culture. Biochim. Biophys. Acta. 1149:1993;305-312.
104. Scherphof G.L., Crommelin D.J.A. Cells involved in removing liposomes from the blood circulation: Why are they so special? J. Liposome Res. 6:1996;19-31.
105. Verkade H.J., Zaal K.J., Derksen J.T., Vonk R.J., Hoekstra D., Kuipers F., Scherphof G.L. Processing of the phospholipid analogue phosphatidyl(N-sulphorhodamine B sulphonyl)ethanolamine by rat hepatocytes in vitro and in vivo. Biochem. J. 284:1992;259-265.
106. Roerdink F.H., Regts J., Van Leeuwen B., Scherphof G.L. Intrahepatic uptake and processing of intravenously injected small unilamellar vesicles in rats. Biochim. Biophys. Acta. 770:1984;195-202.
107. Borensztajn J., Getz G.S., Kotlar T.J. Uptake of chylomicron remnants by the liver: Further evidence for the modulating role of phospholipids. J. Lipid Res. 29:1988;1087-1096.
108. Thuren T., Weisgraber K.H., Sisson P., Waite M. Role of apoE in hepatic lipase catalyzed hydrolysis of phospholipid in high-density lipoproteins. Biochemistry. 31:1982;2332-2338.
109. Wisse E. An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J. Ultrastruct. Res. 31:1970;125-150.
110. Unezaki S., Maruyama K., Hosoda J.-I., Nagae I., Koyanagi Y., Nakata M., Ishida O., Iwatsuru M., Tsuchiya S. Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy. Int. J. Pharm. 144:1996;11-17.
111. Yuan F., Leunig M., Huang S.K., Berk D.A., Papahadjopoulos D., Jain R.K. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res. 54:1994;3352-3356.
112. Spanjer H.H., Van Berkel T.J., Scherphof G.L., Kempen H.J. The effect of a water-soluble tris-galactoside terminated cholesterol derivative on the in vivo fate of small unilamellar vesicles in rats. Biochim. Biophys. Acta. 816:1985;396-402.
113. K. Shimada, J.A.A.M. Kamps, J. Regts, K. Ikeda, T. Shiozawa, S. Hirota, G.L. Scherphof, Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethyleneglycol)s, Biochim. Biophys. Acta, in press.